...
首页> 外文期刊>American Journal of Epidemiology >Supportive Housing and Its Relationship With Diabetes Diagnosis and Management Among Homeless Persons in New York City
【24h】

Supportive Housing and Its Relationship With Diabetes Diagnosis and Management Among Homeless Persons in New York City

机译:纽约市无家可归者在无家可归者中与糖尿病诊断与管理的支持性住房

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Supportive housing addresses a fundamental survival need among homeless persons, which can lead to reduced risk of diabetes mellitus and improved diabetes care. We tested the association between supportive housing and diabetes outcomes among homeless adults who were eligible for New York City's supportive housing program in 2007-2012. We used multiple administrative data sources, identifying 7,525 Medicaid-eligible adults. The outcomes included receiving medical evaluation and management services, hemoglobin A(1C) and lipid testing (n = 1,489 persons with baseline diabetes), and incidence of new diabetes diagnoses (n = 6,036 persons without baseline diabetes) in the 2 years postbaseline. Differences in these outcomes by placement were estimated using inverse-probability-of-treatment weighting. Placed persons were more likely to receive evaluation and management services (relative risk (RR) = 1.03, 95% confidence interval (CI): 1.01, 1.04) than unplaced persons. For those with baseline diabetes, placed persons were more likely to receive hemoglobin A(1C) tests (RR = 1.10, 95% CI: 1.02, 1.19) and lipid tests (RR = 1.09, 95% CI: 1.02, 1.17). For those without baseline diabetes, placement was also associated with lower risk of new diabetes diagnoses (RR = 0.87, 95% CI: 0.76, 0.99). These findings show that benefits of supportive housing may be extended to diabetes care and prevention.
机译:支持性住房涉及无家可归者中的基本生存需要,这可能导致糖尿病患者的风险降低,并改善糖尿病护理。我们在2007 - 2012年在纽约市支持纽约市的支持性房屋计划之间进行了支持性住房和糖尿病成果之间的关联。我们使用了多种行政数据来源,识别7,525个医疗保荐人资格的成年人。结果包括接受医疗评估和管理服务,血红蛋白A(1C)和脂质检测(N = 1,489人,基线糖尿病的人数),以及新糖尿病的发病率在第二岁后2年诊断(N = 6,036人,没有基线糖尿病)。利用逆概率的治疗加权估计通过放置来估算这些结果的差异。被安置的人更有可能接受评估和管理服务(相对风险(RR)= 1.03,95%置信区间(CI):1.01,1.04)而不是未置的人。对于那些有基线糖尿病的人,放置的人更容易接受血红蛋白A(1C)试验(RR = 1.10,95%CI:1.02,119)和脂质试验(RR = 1.09,95%CI:1.02,17)。对于那些没有基线糖尿病的人,展示率也与较低的新糖尿病诊断风险有关(RR = 0.87,95%CI:0.76,0.99)。这些调查结果表明,支撑壳体的益处可能会扩展到糖尿病护理和预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号